 |
 |
Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13
23 July 2009
|
|
|
|
Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore
21 July 2009
|
|
|
Glaxo ties up with Dr Reddy's for emerging markets
15 June 2009
|
| | |
|
|
Dr Reddy’s reorganises drug discovery operation; receives approval for three INDs
21 May 2009
|
|
|
Natco, Dr Reddy’s tie up for cancer generics
16 April 2009
|
|
|
Dr Reddy’s pulling out of small global markets
21 March 2009
|
|
|
Dr Reddy’s sales in Russia and CIS top $150 million
19 March 2009
|
|
|
US court clears Dr Reddy’s in Omeprazole Mg OTC litigation
13 March 2009
|
|
|
Dr Reddy's elevates Saumen Chakraborty as president, corporate and global generics, Umang Vohra as new CFO
02 January 2009
|
|
|
Dr Reddy's, Teva settle `carvedilol' patent dispute: report
12 August 2008
|
|
|
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
|
|
|
Dr Reddy’s to buy back Perlecan Pharma stake from ICICI Ventures and Citigroup
22 July 2008
|
|
|
Dr. Reddy's in global Ibuprofen marketing pact with Albemarle
09 July 2008
|
|
|
Dr Reddy's acquires BASF's contract manufacturing business in US
30 April 2008
|
|
|
Dr Reddy's acquires Jet Generici Srl; to establish generics range in Italy
03 April 2008
|
|
|
Dr Reddy's to buy two Dowpharma Small Molecules units in the UK
01 April 2008
|
|
|
Dr Reddy's Laboratories and 7TM Pharma sign drug research pact
10 March 2008
|
|
|
Dr Reddy's announces settlement of Exelon (rivastigmine tartrate ) ANDA litigation with Novartis
21 January 2008
|
|
|
Dr Reddy's gets US FDA nod for marketing Ciprofloxacin
17 November 2007
|
|
|
Dr Reddy's and Rheoscience commence Phase III diabetes drug trials
02 August 2007
|
|
|
Dr Reddy's commences operations in Nigeria
16 June 2007
|
|
|
Dr Reddy's is setting up two SEZs
19 May 2007
|
|
|
Dr Reddy's to join the race for Merck's generic business
05 February 2007
|
|
|
Wockhardt, Dr Reddy's launch generic Ondansetron in the US
27 December 2006
|
|
|
Dr Reddy's to raise Rs 1,027 crore through additional ADS issue
30 November 2006
|
|
|
Torrent
in pact with DRL to market Listril and Listril Plus in
Russia
29 November 2006
|
|
|
US
Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s
15 November 2006
|
|
|
Dr Reddy's plans $235 million ADR issue
14 November 2006
|
|
|
Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row
10 October 2006
|
|
|
Dr Reddy’s, ClinTec International announce co-development of anti-cancer compound
28 September 2006
|
|
|
Dr Reddy's opens manufacturing facility at Visakhapatnam
26 September 2006
|
|
|
Dr Reddy's acquires Spain's Litaphar: CNBC
18 September 2006
|
|
|
Dr Reddy's Q4 losses rise 60 per cent
01 June 2006
|
|
|
Dr Reddy's launches oral bronchodilator for asthma, COPD
16 May 2006
|
|
|
Dr Reddy's receives US FDA approval for fexofenadine hydrochloride
13 April 2006
|
|
|
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
|
|
|
Dr Reddy's beats Ranbaxy; snaps up Betapharm for €480 million
16 February 2006
|
|
|
Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm
03 February 2006
|
|
|
Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs
02 February 2006
|
|
|
Dr Reddy's Laboratories enters into agreement with Merck
01 February 2006
|
|
|
Dr Reddy''s to acquire Roche business in Mexico
08 November 2005
|
|
|
Dr Reddy''s cardio drug candidate undergoing clinical trials
09 February 2005
|
|
|
Acer and TVS Electronics enable sales force automation for Dr Reddy's Laboratories
20 July 2004
|
|
|
FIIs pull out of Dr Reddy''s Laboratories
31 May 2004
|
|
|
Dr Reddy''s acquires US company Trigenesis
07 May 2004
|
|
|
US reinsurers wary of Indian pharma firms
09 March 2004
|
|
|
FIIs,
banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal,
Cipla
21 July 2003
|
|
|
Novartis
discontinues development of Dr Reddy’s compound
24 January 2003
|
|
|
Dr Reddy’s Labs to appeal US court ruling on infringement
14 October 2002
|
|
|
Dr
Reddy’s grants employee stock options
27 August 2002
|
|
|
Dr Reddys
buys Group Pharma brands
26 December 2001
|
|
|
Novartis
goes on with Dr Reddys work
26 December 2001
|
|
|
Dr Reddys
can now sell Zafirlukast
15 December 2001
|
|
|
Leading
firms, Specialty Ranbaxy tie up
01 December 2001
|
|
|
in China
28 November 2001
|
|
|
Dr Reddys
to challenge patents on drugs
26 November 2001
|
|
|
The
future is bright for pharma firms
21 November 2001
|
|
|
Dr Anji Reddy felicitated by IPA
28 June 2001
|
|
|
About ovarian cancer
28 January 2000
|
|
|
About small-cell lung cancer
28 January 2000
|
|
|
Dr Reddy''s launch anti-cancer
drug topotecan
28 January 2000
|
|
|
Cheminor
Drugs Q3 sales down 10 per cent
06 January 2000
|
|
|
Formulations exports pushed Dr
Reddy''s sales up 35 pc
06 January 2000
|
|
|
Cheminor Drugs
Ltd.
02 December 1999
|
|
|
Dr. Reddy''s Laboratories Ltd.
02 December 1999
|
|
|
Dr Reddy''s acquires 45% stake in
American Remedies
26 November 1999
|
|
|
DRF 1042 to enter phase 1 trials
in August
04 July 1999
|
|
|
Cheminor unfazed by AstraZeneca
patent infringement suit
13 May 1999
|
